Guohai H. Su
No. 105, Jiefang Road
Jinan, 250013, China
Jinan, 250013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
Risk Prediction of Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention Using Inflammatory Biomarkers.
Journal: Journal of visualized experiments : JoVE
Published: July 06, 2026
Cardiomyocyte-Specific RNF128 Attenuates Pathological Cardiac Hypertrophy Progression by Stabilizing SERCA2a through Lys63-Linked Polyubiquitination.
Journal: Theranostics
Published: February 15, 2026
Sex-specific associations between pregnancy zone protein and acute coronary syndrome: a case-control study.
Journal: Biology of sex differences
Published: January 12, 2026
DSCAML1+ extracellular vesicles revealed by single-vesicle proteomics as a novel biomarker and therapeutic target in myocardial infarction.
Journal: Journal of nanobiotechnology
Published: January 05, 2026
Meteorin-like protein inhibits vascular smooth muscle cell-derived foam cell formation and atherosclerosis via KIT- endoplasmic reticulum stress signaling.
Journal: Metabolism: clinical and experimental
Published: July 17, 2025
Global, regional, and national burden of cardiovascular diseases attributable to high body mass index from 1990 to 2021.
Journal: Frontiers in cardiovascular medicine
Published: June 05, 2025
Ticagrelor vs. clopidogrel in bivalirudin-treated patients with STEMI undergoing primary PCI: The BRIGHT-4 trial.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: April 03, 2025
Macrophage SBK2 suppresses inflammation and atherosclerosis by NLRP3 phosphorylation.
Journal: European heart journal
Published: March 17, 2025
Enhancing autophagy mitigates LPS-induced neuroinflammation by inhibiting microglial M1 polarization and neuronophagocytosis.
Journal: Frontiers in cellular neuroscience
Published: December 17, 2024
The pharmacokinetics and Concentration-QTc analysis of a new etomidate analog ET-26-HCl: a phase I trial in healthy Chinese subjects.
Journal: Frontiers in pharmacology
Published: November 26, 2024
Last Updated: 09/26/2026